The soluble isoform of TREM-2, has been reported to be increased in the cerebrospinal fluid of multiple sclerosis patients[31]and it is postulated that, as it happens with the sTREM-1, it would inhibit TREM-2 bound receptor function. This evidence concerns the gene TREM2 and multiple sclerosis.